Oneview Healthcare Plc (ASX:ONE) shares traded at $0.12, down 14.29%, during theTrading sessionon 26 October 2026, while the S&P/ASX 200index(XJO) stood at 8,805.30, up 0.11% or 10.10 points, at 2:06 pm. Separately, the company's latest announcement on file is dated 6-month period ended 30 …
Oneview Healthcare (ASX:ONE) at $0.12, down 14.29%, Adheris Health (ASX:AHE) at $0.013, down 13.33% and Little Green Pharma (ASX:LGP) at $0.059, down 9.23% were among the ASX decliners during theTrading sessionon 26 October 2026, while the S&P/ASX 200index(XJO) stood at 8,805.30, up 0.11% or …
Argent Biopharma Ltd (ASX:RGT) shares traded at $0.029, down 9.38%, during theTrading sessionon 26 October 2026, while the S&P/ASX 200index(XJO) stood at 8,805.30, up 0.11% or 10.10 points, at 2:06 pm. Separately, the company's latest announcement on file is dated 23 October 2026 and …
INOVIQ Ltd (ASX:IIQ) announced on 23 October 2026 that Dr Leearne Hinch will step down as chief executive officer on 27 October 2026. The company said the change was mutually agreed between the board and Dr Hinch. Chairman Peter Gunzburg will become executive chair …
The voluntary administrators of Paradigm Biopharmaceuticals Limited (ASX:PAR) (Administrators Appointed) have applied to the Supreme Court of Western Australia to extend the convening period for the second meeting of creditors by up to three months. Separately, the company has paid US$348,900.38 to redeem a …
Proteomics International Laboratories (ASX:PIQ) has announced the national rollout of two of its Promarker diagnostic tests, PromarkerD and PromarkerEso, through its exclusive Australian pathology distribution partner, Healius Limited (ASX:HLS). The company said the rollout and supporting systems are scheduled to go live on Monday …
Argent BioPharma (ASX:RGT) has released its Appendix 4C and quarterly activities report for the three months to 30 September 2026. The reported figures are a net operating cash outflow of A$734,000 and closing cash of A$11,000, with A$600,000 drawn from convertibleDebtsecurities. The company also …
Arovella Therapeutics Limited (ASX:ALA) said in its quarterly update for the period ended 30 September 2026 that its focus is ALA-101, a CD19-targeted CAR-iNKT cell therapy for blood cancers. The company said two manufacturing batches were manufactured and released for clinical use in September …
Amplia Therapeutics Limited (ASX:ATX) has received A$4,778,235.52 from the Australian Taxation Office under theResearch and DevelopmentTax Incentive, covering the financial year ended 31 March 2026. The company announced the receipt on 22 October 2026.
Doctor Care Anywhere Group (ASX:DOC), a UK company with CDIs on the ASX, published a Strategy and Business Model Update and a short-form investor primer on 23 October 2026 (Sydney time). The documents contain no forecasts, targets or new results. They restate the company's …